Pfizer: The Tide Finally Turning

Summary:

  • Pfizer, a multinational pharmaceutical and biotechnology corporation, is now a $159 billion (by market cap) healthcare giant.
  • With business and stock excess seemingly totally wrung out, and with expectations now about as low as ever, long-term investors holding or buying from this starting point could be positioned well, as Pfizer has recently shown exciting signs of bouncing back into growth.
  • Pfizer has increased its dividend for 14 consecutive years, with a 10-year dividend growth rate of 10.2%.
  • Pfizer increased its revenue from $49.6 billion in FY 2014 to $58.5 billion in FY 2023, a compound annual growth rate of 1.9%.

Pfizer HQ in New York City

georgeclerk

Pfizer Inc. (NYSE:PFE) is a multinational pharmaceutical and biotechnology corporation. Founded in 1849, Pfizer is now a $159 billion (by market cap) healthcare giant that employs approximately 88,000 people.

The company’s FY 2023 revenue is broken down into



Leave a Reply

Your email address will not be published. Required fields are marked *